# Study Evaluating FXR-450 in Healthy Japanese Men

> **NCT00509756** · PHASE1 · TERMINATED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** FXR-450
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00509756
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-11
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Please see termination statement in the detailed description.
- **Last updated:** 2010-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509756, "Study Evaluating FXR-450 in Healthy Japanese Men". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00509756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*